Stephanie Daukus
Stephanie Daukus

Krispy Kreme appoints Stephanie Daukus as VP of investor relations. Daukus joins the company from Olo, a B2B SaaS company that develops digital ordering and delivery programs for restaurants, where she led the investor relations function. She has also held senior IR posts at Envestnet and Thomson Reuters. In her new role, Daukus will oversee Krispy Kreme’s investor relations practices, including the communication of its financial performance and corporate strategy to the investment community and serving as the primary point of contact for analysts and investors. “She has a proven track record of execution across investor relations roles in multiple industries and will continue to drive consistency and transparency in our communications with the investment community,” said Krispy Kreme executive VP and CFO Jeremiah Ashukian.

Neville Letzerich
Neville Letzerich

Talkdesk, a cloud contact center platform, brings on Neville Letzerich as CMO. Letzerich was most recently vice president and CMO at Cisco Security, handling global end-to-end marketing and growth strategy. He previously held the CMO spot at companies including Forescout Technologies, Virtru and Duo Security. At Talkdesk, Letzerich will lead the company’s marketing organization and sales development initiatives. “I’ve worked with Neville in the past and have witnessed firsthand his ability to create a unique value proposition among a crowded market,” said Talkdesk president and chief operating officer William Welch.

Patrick Malloy
Patrick Malloy

Abivax, a French clinical-stage biotech company, appoints Patrick Malloy as senior VP, investor relations. Malloy comes to Abivax from VectivBio, where he was senior VP, investor relations & strategic communications. Before that, he was VP investor relations & corporate communications at Arena Pharmaceuticals. At Abivax, Malloy is expected to play a crucial role in furthering the strategic international positioning of Abivax and its obefazimod (a treatment for patients with moderate-to-severe, active ulcerative colitis) with the investor community. Malloy will be based at the Abivax office on the U.S. East Coast. “I am glad Patrick joins our team with his extensive experience in investor relations and commercial as well as a proven track record as a strategic leader in the biopharma sector,” said Abivax chief financial officer Didier Blondel.